Announcements

The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
Call for Nominations for the 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA invites nominations for its annual Innovations in Regulatory Science & Policy Awards.
Read More
More Announcements

Coverage

FDA Awards $2.51 Million Contract That Includes Cannabis Public Health Messaging Campaign
The contract was awarded last week to the Reagan-Udall Foundation for the FDA for $2,510,454. The Reagan-Udall Foundation is also expected to produce a white paper and communications report summarizing the stakeholder process and testing results and…
Read More
Longevity Drugs Need Endpoints That Predict Clinical Benefit
Candidate measures that could be linked to the biology of aging were discussed at a May 2026 public meeting convened by the Reagan-Udall Foundation for the FDA with the Advanced Research Projects Agency for Health.
Read More
BRC Therapeutics Joins FDA And EMA Regulators At Workshop Advancing The Future Of Botanical Drug Development
The workshop also builds on an invitation-only botanical drug development roundtable that the FDA's Center for Drug Evaluation and Research convened with the Reagan-Udall Foundation for the FDA.
Read More
More Coverage